Stage IIA Prostate Cancer Recruiting Phase 2 Trials for Phenelzine (DB00780)

IndicationStatusPhase
DBCOND0028878 (Stage IIA Prostate Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02217709Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate CancerTreatment